CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 33 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $404,000 | -52.0% | 505,702 | -42.4% | 0.00% | – |
| Q2 2018 | $841,000 | -8.5% | 877,476 | +72.7% | 0.00% | – |
| Q1 2018 | $919,000 | +174.3% | 508,106 | +125.5% | 0.00% | – |
| Q4 2017 | $335,000 | +4685.7% | 225,309 | +3923.4% | 0.00% | – |
| Q2 2017 | $7,000 | – | 5,600 | +2700.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 200 | -96.1% | 0.00% | – |
| Q2 2016 | $19,000 | +533.3% | 5,139 | +654.6% | 0.00% | – |
| Q1 2016 | $3,000 | -62.5% | 681 | -39.1% | 0.00% | – |
| Q4 2015 | $8,000 | -33.3% | 1,118 | -27.1% | 0.00% | – |
| Q3 2015 | $12,000 | -58.6% | 1,533 | -36.1% | 0.00% | – |
| Q2 2015 | $29,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $4,572,000 | 5.05% |
| Clarus Ventures, LLC | 2,752,488 | $4,404,000 | 3.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 388,030 | $621,000 | 0.12% |
| Rhenman & Partners Asset Management AB | 310,756 | $497,000 | 0.08% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $39,000 | 0.01% |
| OPPENHEIMER & CO INC | 90,000 | $144,000 | 0.00% |
| Alyeska Investment Group, L.P. | 221,281 | $354,000 | 0.00% |
| A.R.T. Advisors, LLC | 46,747 | $74,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,347 | $162,000 | 0.00% |
| Acrospire Investment Management LLC | 680 | $1,000 | 0.00% |